Chad: Medical professionals advocate for misoprostol use to reduce maternal deaths
An workshop focused on advocating for the use of misoprostol in reducing maternal mortality from postpartum hemorrhage (PPH) and in abortion care (SAA) opened on June 25 in N'Djamena, Chad. The workshop aims to strengthen advocacy for the improved integration of misoprostol into existing policies and practices. Obstetricians and midwives are specifically calling for its wider application. The event highlights the ongoing efforts within Chad to address critical issues in maternal healthcare. Misoprostol is recognized for its potential to significantly impact outcomes related to PPH, a leading cause of maternal death globally. Furthermore, its role in safe abortion care is also a key point of discussion. The workshop brings together medical professionals to collectively push for these advancements. The goal is to ensure that misoprostol becomes a more accessible and routinely used medication in maternal health services across the country. This initiative underscores the importance of evidence-based interventions in improving maternal and reproductive health outcomes.
This workshop in N'Djamena signifies a crucial step in advocating for evidence-based medical interventions to combat maternal mortality in Chad. By focusing on misoprostol, healthcare professionals are seeking to leverage a known effective treatment for postpartum hemorrhage and safe abortion care. The initiative highlights a systemic need to update medical policies and practices to align with global health standards. The challenge lies in overcoming potential barriers to adoption, such as supply chain issues, training requirements, and cultural acceptance. Strengthening advocacy efforts is essential to ensure that such vital medications are integrated effectively, ultimately aiming to reduce preventable maternal deaths and improve reproductive health outcomes for women in Chad over the next decade.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.